Amgen (AMGN) just unveiled an update.
Amgen Inc.’s stockholders have given the green light to an important update of the company’s equity incentive plan, allowing for an additional 31 million shares to be issued and adjusting the payment of dividend equivalents to depend on award vesting. Furthermore, the plan now ensures full vesting of awards in the event of a change of control. At the recent Annual Meeting, all 12 director nominees were elected for a one-year term, with Dr. Klotman added to two key committees. Shareholders also endorsed executive compensation and reappointed Ernst & Young LLP as the company’s independent accountants for the upcoming fiscal year.
Find detailed analytics on AMGN stock on TipRanks’ Stock Analysis page.
